Addex Therapeutics Ltd (FRA:APE)
Germany
· Delayed Price · Currency is EUR 0.0560
0.00 (0.00%)
At close: Dec 3, 2025
Addex Therapeutics Statistics
Total Valuation
FRA:APE has a market cap or net worth of EUR 6.64 million. The enterprise value is 4.35 million.
| Market Cap | 6.64M |
| Enterprise Value | 4.35M |
Important Dates
The last earnings date was Monday, November 10, 2025.
| Earnings Date | Nov 10, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
| Current Share Class | 111.25M |
| Shares Outstanding | n/a |
| Shares Change (YoY) | +9.98% |
| Shares Change (QoQ) | +2.21% |
| Owned by Insiders (%) | 18.63% |
| Owned by Institutions (%) | 2.25% |
| Float | 88.53M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 39.21 |
| PB Ratio | 1.04 |
| P/TBV Ratio | 1.04 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -0.67 |
| EV / Sales | 25.70 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 2.01, with a Debt / Equity ratio of 0.01.
| Current Ratio | 2.01 |
| Quick Ratio | 1.91 |
| Debt / Equity | 0.01 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -1,653.27 |
Financial Efficiency
Return on equity (ROE) is -72.84% and return on invested capital (ROIC) is -18.13%.
| Return on Equity (ROE) | -72.84% |
| Return on Assets (ROA) | -15.90% |
| Return on Invested Capital (ROIC) | -18.13% |
| Return on Capital Employed (ROCE) | -40.30% |
| Revenue Per Employee | 84,729 |
| Profits Per Employee | -3.26M |
| Employee Count | 2 |
| Asset Turnover | 0.02 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
| Beta (5Y) | n/a |
| 52-Week Price Change | n/a |
| 50-Day Moving Average | 0.05 |
| 200-Day Moving Average | n/a |
| Relative Strength Index (RSI) | 59.88 |
| Average Volume (20 Days) | n/a |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, FRA:APE had revenue of EUR 169,457 and -6.52 million in losses. Loss per share was -0.07.
| Revenue | 169,457 |
| Gross Profit | 99,607 |
| Operating Income | -2.65M |
| Pretax Income | -6.63M |
| Net Income | -6.52M |
| EBITDA | -2.62M |
| EBIT | -2.65M |
| Loss Per Share | -0.07 |
Balance Sheet
The company has 2.34 million in cash and 39,066 in debt, giving a net cash position of 2.30 million.
| Cash & Cash Equivalents | 2.34M |
| Total Debt | 39,066 |
| Net Cash | 2.30M |
| Net Cash Per Share | n/a |
| Equity (Book Value) | 6.37M |
| Book Value Per Share | 0.04 |
| Working Capital | 1.27M |
Cash Flow
| Operating Cash Flow | -1.68M |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
| Gross Margin | 58.78% |
| Operating Margin | -1,564.90% |
| Pretax Margin | -3,910.01% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
FRA:APE does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -9.98% |
| Shareholder Yield | -9.98% |
| Earnings Yield | -98.07% |
| FCF Yield | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 2 |